
Conference Coverage
1 day ago
ICYMI: Highlights From SABCS 20251 day ago
ICYMI: Highlights From COA 20252 days ago
ICYMI: Highlights From ASH 20258 days ago
ICYMI: Highlights From ASCO 202511 days ago
ICYMI: Highlights From AMCP 2025Latest Content

Meta-Analysis Supports RSV Vaccine Efficacy and Safety in Older Adults

ICYMI: Highlights From MDA 2025

Reducing Financial Toxicity in Oncology Requires Earlier Screening, Payer-Provider Collaboration: Scott Soefje, PharmD, MBA, BCOP

Top 5 Most-Read Obesity Content of 2025

Standardized Definition, Smarter Treatment Approaches Needed for Acute Chronic Rhinosinusitis Exacerbations

Shorts










Podcasts
Center on Health Equity & Access
All News

The most-read content for HIV focused on funding cuts to HIV aid and research and satisfaction with telemedicine for HIV care.

The most-read articles focused on soft tissue sarcoma research, including innovative biomarkers, treatment strategies, and multidisciplinary care challenges.

New therapies and individualized care plans for menopausal women highlighted the most-read 2025 SABCS coverage.

These are the most popular multiple myeloma articles from 2025.

Explore the evolving landscape of drug pricing, reproductive rights, and health policy in 2025, featuring insights on SC pembrolizumab and RFK Jr's hearings.

Exercise enhances quality of life and sleep for those with ovarian cancer, highlighting the need for further research in supportive care.

The 2025 Community Oncology Conference, hosted by COA, reflected a commitment to patient-centered care, access, and innovation in community oncology.

ASH 2025 reveals groundbreaking trial data on fixed-duration therapies for chronic lymphocytic leukemia, non-Hodgkin lymphoma, and multiple myeloma, enhancing patient outcomes and reducing costs.

The most-viewed content focused on the “One Big Beautiful Bill,” the Most Favored Nation drug policy, and other changes under the Trump administration.

Our top dermatology content of 2025 highlights AI wearables, new biologics, emerging vitiligo treatments, and strategies for rare and complex skin diseases.




















